Answers are grounded in this paper and cite their sources.
Analysis of antimicrobial activity reveals microbacterin A from Microbacterium sp. HN-3-14, suggesting potential applications in antibiotic development.
One novel mevalonolactone‐pyrimidine hybrid (microbacterin A, 1 ), two undescribed acetylglucosamine derivatives, N ‐((2 S ,5 R )‐5‐(( R )‐1,2‐dihydroxyethyl)‐2‐methoxy‐2,5‐dihydrofuran‐3‐yl)acetamide ( 2 ), N ‐((2 R ,5 R )‐5‐(( R )‐1,2‐dihydroxyethyl)‐2‐methoxy‐2,5‐dihydrofuran‐3‐yl)acetamide ( 3 ) along with five known compounds ( 4 − 8 ), namely, niacinamide ( 4 ), 7,8‐dimethylalloxazine ( 5 ), adenine ( 6 ), adenosine ( 7 ), and deoxyadenosine ( 8 ), were isolated from the fermentation broth of a marine bacterium, Microbacterium sp. HN‐3‐14. Their structures and absolute configurations were elucidated through comprehensive spectroscopic analyses, including HR‐ESI‐MS, 1D and 2D NMR, theoretical ECD and NMR calculations, and dimolybdenum tetraacetate–induced CD (ICD) measurements. Antimicrobial experiments showed that 5 exhibited a weak inhibitory effect on Saccharomyces cerevisiae at the dose of 80 µg/mL.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: